Anti-inflammatory therapies for CVD risk prevention
Ulrich Laufs, MD, PhD
Anti-inflammatory effects of GLP-1RA in T2D
Rein Oostveen, MD
Stephen Nicholls, MD
Jeanine Roeters van Lennep, MD, PhD
Pierre Sabouret, MD, PhD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.